Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CVRX

CVRx (CVRX) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $1.58 -6.0% on the day -82.8% over 12 months 52-week range $1.53 – $10.81

Share price and insider trades

CVRX closeInsider buyInsider sale
051015NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $2,000 on 2025-11-07 · Johnson & Johnson Innovation - Jjdc, Inc.Bought $2,784 on 2026-02-18 · Mudit K. JainSold $3,338 on 2026-08-12 · Brent BinkowskiSold $5,000 on 2025-11-21 · & Johnson JohnsonSold $10,000 on 2025-11-12 · & Johnson JohnsonSold $22,132 on 2025-11-24 · & Johnson JohnsonBought $76,309 on 2026-08-13 · Brent BinkowskiSold $126,534 on 2026-03-02 · Jared Oasheim, Kevin Hykes, Paul Verrastro, Philip B. Adamson, Robert Allen JohnSold $127,120 on 2025-11-26 · & Johnson Johnson, Johnson & Johnson Innovation - Jjdc, Inc.Sold $160,480 on 2025-11-25 · Johnson & Johnson Innovation - Jjdc, Inc.Bought $297,648 on 2026-02-20 · Mudit K. JainSold $534,310 on 2025-11-06 · Johnson & Johnson Innovation - Jjdc, Inc.
Bought, 12 months$374K
Sold, 12 months$991K
Insiders buying2
Insiders selling8

CVRx insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $374K and 8 sold $991K of CVRX stock on the open market.

CVRX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $861K sold (8 trades)Q4 2025Q1 2026: $300K bought (2 trades)$300KQ1 2026: $127K sold (5 trades)Q1 2026Q2 2026Q3 2026: $76K bought (1 trades)$76KQ3 2026: $3K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$76K1$3K1
Q2 2026—0—0
Q1 2026$300K2$127K5
Q4 2025—0$861K8

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.5×Last 5 sessions
Insiders' paper profit−$260KOn all tracked purchases -69.1%

Summary

Over the past 12 months, 2 CVRx, Inc. insiders reported open-market purchases totaling $374K, while 8 insiders reported sales totaling $991K. 6 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 13SEC Brent BinkowskiCOO Buy 26,22356,514 held (+87%) $2.91 $76K -45.7% —
Aug 13SEC Brent BinkowskiCOO Sell Plan 1,30930,291 held (−4%) $2.55 $3K -38.0% —
Mar 16SEC Philip B. AdamsonChief Medical Officer Sell Plan 1,26261,578 held (−2%) $7.90 $10K -80.0% —
Mar 3SEC Kevin HykesCEO Sell Plan 7,763284,237 held (−3%) $7.90 $61K -80.0% —
Mar 3SEC Robert Allen JohnChief Revenue Officer Sell Plan 3,96486,036 held (−4%) $7.90 $31K -80.0% —
Mar 3SEC Jared OasheimCFO Sell Plan 1,74496,703 held (−2%) $7.90 $14K -80.0% —
Mar 3SEC Paul VerrastroChief Mktg & Strat Officer Sell Plan 1,28460,551 held (−2%) $7.90 $10K -80.0% —
Feb 23SEC Mudit K. JainDirector Buy 46,800980,183 held (+5%) $6.36 $298K -75.2% —
Feb 18SEC Mudit K. JainDirector Buy 6005,650 held (+12%) $4.64 $3K -65.9% —
Jan 8SEC Johnson & Johnson Innovation - Jjdc, Inc.10% Owner Sell 16,0004,031,198 held (−0%) $10.03 $160K -84.2% —
Jan 8SEC Johnson & Johnson Innovation - Jjdc, Inc.10% Owner Sell 6,3374,024,861 held (−0%) $10.03 $64K -84.2% —
Dec 1SEC & Johnson Johnson10% Owner Sell 6,3374,040,861 held (−0%) $10.03 $64K -84.2% —
Nov 25SEC & Johnson Johnson10% Owner Sell 2,2004,047,198 held (−0%) $10.06 $22K -84.3% —
Nov 25SEC & Johnson Johnson10% Owner Sell 5004,049,398 held (−0%) $10.00 $5K -84.2% —
Nov 14SEC & Johnson Johnson10% Owner Sell 1,0004,049,898 held (−0%) $10.00 $10K -84.2% —
Nov 10SEC Johnson & Johnson Innovation - Jjdc, Inc.10% Owner Sell 52,3324,051,098 held (−1%) $10.21 $534K -84.5% —
Nov 10SEC Johnson & Johnson Innovation - Jjdc, Inc.10% Owner Sell 2004,050,898 held (−0%) $10.00 $2K -84.2% —

Insiders at CVRx, Inc.

InsiderBoughtSoldLast filingScore
Mudit K. JainDirector $300K — Feb 23, 2026 —
Johnson & Johnson Innovation - Jjdc, Inc.10% Owner — $760K Jan 8, 2026 —
Brent BinkowskiCOO $76K $3K Aug 13, 2026 —
& Johnson Johnson10% Owner — $101K Dec 1, 2025 —
Kevin HykesCEO — $61K Mar 3, 2026 —
Robert Allen JohnChief Revenue Officer — $31K Mar 3, 2026 —
Jared OasheimCFO — $14K Mar 3, 2026 —
Paul VerrastroChief Mktg & Strat Officer — $10K Mar 3, 2026 —
Philip B. AdamsonChief Medical Officer — $10K Mar 16, 2026 —

CVRX stock: common questions

Are CVRx, Inc. insiders buying CVRX stock?

In the past 12 months, 2 insiders reported open-market purchases of CVRX worth $374K. The latest was COO Brent Binkowski bought $76K of CVRX at $2.91 — first open-market purchase in our records; raises the stake by 87%.

Are CVRx, Inc. insiders selling CVRX stock?

8 insiders reported sales worth $991K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CVRX's 52-week range?

Over the past year CVRX has traded between $1.53 and $10.81. It last closed at $1.58 on Oct 9, 2026.